Literature DB >> 16990264

Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.

Masamichi Nagae1, Nozomu Nishi, Takeomi Murata, Taichi Usui, Takanori Nakamura, Soichi Wakatsuki, Ryuichi Kato.   

Abstract

The galectins are a family of beta-galactoside-binding animal lectins with a conserved carbohydrate recognition domain (CRD). They have a high affinity for small beta-galactosides, but binding specificity for complex glycoconjugates varies considerably within the family. The ligand recognition is essential for their proper function, and the structures of several galectins have suggested their mechanism of carbohydrate binding. Galectin-9 has two tandem CRDs with a short linker, and we report the crystal structures of mouse galectin-9 N-terminal CRD (NCRD) in the absence and the presence of four ligand complexes. All structures form the same dimer, which is quite different from the canonical 2-fold symmetric dimer seen for galectin-1 and -2. The beta-galactoside recognition mechanism in the galectin-9 NCRD is highly conserved among other galectins. In the apo form structure, water molecules mimic the ligand hydrogen-bond network. The galectin-9 NCRD can bind both N-acetyllactosamine (Galbeta1-4GlcNAc) and T-antigen (Galbeta1-3GalNAc) with the proper location of Arg-64. Moreover, the structure of the N-acetyllactosamine dimer (Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAc) complex shows a unique binding mode of galectin-9. Finally, surface plasmon resonance assay showed that the galectin-9 NCRD forms a homophilic dimer not only in the crystal but also in solution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990264     DOI: 10.1074/jbc.M606648200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen.

Authors:  Lei Feng; Hui Sun; Ying Zhang; De-Feng Li; Da-Cheng Wang
Journal:  FASEB J       Date:  2010-06-07       Impact factor: 5.191

2.  Galectin multimerization and lattice formation are regulated by linker region structure.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  Glycobiology       Date:  2010-09-23       Impact factor: 4.313

3.  CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

Authors:  Elizabeth Ann L Enninga; Kyriakos Chatzopoulos; John T Butterfield; Shari L Sutor; Alexey A Leontovich; Wendy K Nevala; Thomas J Flotte; Svetomir N Markovic
Journal:  J Pathol       Date:  2018-06-28       Impact factor: 7.996

4.  Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans.

Authors:  Hiroko Ideo; Tsutomu Matsuzaka; Takamasa Nonaka; Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

Review 5.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

6.  Galectin-9 binds to O-glycans on protein disulfide isomerase.

Authors:  Katrin Schaefer; Nicholas E Webb; Mabel Pang; Jenny E Hernandez-Davies; Katharine P Lee; Pascual Gonzalez; Martin V Douglass; Benhur Lee; Linda G Baum
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

7.  X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose.

Authors:  Hiromi Yoshida; Misa Teraoka; Nozomu Nishi; Shin-ichi Nakakita; Takanori Nakamura; Mitsuomi Hirashima; Shigehiro Kamitori
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

8.  Dimeric Galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the C-terminal domain.

Authors:  Sean R Stowell; Connie M Arthur; Kristin A Slanina; John R Horton; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

9.  In primed allo-tolerance, TIM-3-Ig rapidly suppresses TGFbeta, but has no immediate effect on Foxp3.

Authors:  Poorni A D S Muthukumarana; Xin X Zheng; Bruce R Rosengard; Terry B Strom; Susan M Metcalfe
Journal:  Transpl Int       Date:  2008-02-16       Impact factor: 3.782

10.  Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis.

Authors:  Prasun Guha; Engin Kaptan; Gargi Bandyopadhyaya; Sabina Kaczanowska; Eduardo Davila; Keyata Thompson; Stuart S Martin; Dhananjaya V Kalvakolanu; Gerardo R Vasta; Hafiz Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.